| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |